Una candidatura completa in un minuto
Curriculum e lettera di presentazione personalizzati, pronti da inviare.
Magle Biopolymers in Denmark seeks a Business Controller to become the single source of financial truth for the Køge and Hårlev sites. You will build the cost model on top of Dynamics 365 Business Central and partner with operations and management on steering the business.
You will own the annual budget, provide monthly close input via an outsourced accounting team, and deliver cost-per-unit visibility to support decisive action.
Magle Biopolymers is part of the Magle Group - an international life science group with strong roots in dextran technology. We develop and manufacture advanced polymer-based materials used in medical products, contributing to improving patients’ lives.
As a CDMO entity within the group, Magle Biopolymers operates in a regulated environment with high quality requirements. Quality, accountability, and cross-functional collaboration are core elements of our daily work, and we continuously strive to improve our processes and solutions.
In the newly established role of Business Controller, you will become part of the Biopolymers business unit, reporting directly to the CEO of Biopolymers with a functional line to the Group Finance Director. You will be the single source of financial truth for the business - building the cost model and controlling framework on top of Microsoft Dynamics 365 Business Central, which we implemented in August 2026, and making the financial consequences visible where operational and commercial decisions are taken. Bookkeeping and the monthly close are handled by our outsourced Accounting team, so your focus is on financial steering and business partnering. The position is based in Køge with regular presence at our site in Hårlev.
For questions, please contact HR Manager Rikke Tjustrup at rikke.tjustrup@maglegroup.com.
Magle Group has a solid history within life science and has grown through strategic acquisitions. Today, the group consists of several specialized entities, including Magle Biopolymers, with a strong focus on dextran technology and CDMO services.